Brief: Day One Says OJEMDA 2026 U.S. Net Product Revenue Projected To Be $225 - $250 Million
11/01/2026 22:04
Jan 11 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O: DAY ONE ANNOUNCES PRELIMINARY 2025 OJEMDA™ NET PRODUCT REVENUE AND PROVIDES 2026 NET PRODUCT REVENUE GUIDANCE DAY ONE BIOPHARMACEUTICALS INC - OJEMDA 2026 U.S. NET PRODUCT REVENUE PROJECTED TO BE $225 - $250 MILLION Source text: ID:nGNX40q6rJ Further company coverage: DAWN.O ((Reuters.briefs@thomsonreuters.com;))